{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-152834","form_type":"8-K","ticker":"XENE","cik":"0001582313","company_name":"Xenon Pharmaceuticals Inc.","filed_at":"2026-04-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.516183+00:00","generated_at":"2026-05-15T06:35:10.494733+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Xenon increases inducement equity plan share reserve from 900k to 1.175M shares","bullets":["Amended 2025 Inducement Plan to raise maximum shares reserved from 900,000 to 1,175,000, a 30.6% increase.","Shares are reserved exclusively for inducement grants (nonstatutory options, RSUs, etc.) to new employees.","Amendment approved by independent directors; shareholder approval not obtained per Nasdaq Rule 5635(c)(4).","Plan amended effective April 7, 2026; full text filed as Exhibit 10.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-152834","json":"https://secwatch.observer/filing/0001193125-26-152834.json","markdown":"https://secwatch.observer/filing/0001193125-26-152834.md","text":"https://secwatch.observer/filing/0001193125-26-152834.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526152834/0001193125-26-152834-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526152834/xene-20260407.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:35:10.494733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}